Literature DB >> 20389137

Paraneoplastic neurological syndromes and the role of PET imaging.

Chrissa Sioka1, Andreas Fotopoulos, Athanassios P Kyritsis.   

Abstract

Paraneoplastic neurological syndromes are immune-mediated effects of cancer that involve the nervous system and are associated with various anti-neuronal antibodies. They can be associated with several cancers such as lung, gynecologic, thymic, testicular and others, but the diagnosis of cancer often becomes a challenge, since paraneoplastic neurological syndromes usually precede the cancer presentation by months or even years. Furthermore, even when the cancer develops, the tumor size remains small and usually undetectable by conventional diagnostic tests and imaging. Positron emission tomography imaging may be an adjunct to timely diagnosis of the occult malignancy in order to employ the specific cancer treatment. Furthermore, positron emission tomography can assess the extent of the functional abnormality in the brain and monitor its response to treatment. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20389137     DOI: 10.1159/000312657

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

1.  Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer.

Authors:  Domenico Plantone; Pietro Caliandro; Raffaele Iorio; Giovanni Frisullo; Viviana Nociti; Agata Katia Patanella; Alessandro Marti; Pietro Attilio Tonali; Anna Paola Batocchi
Journal:  J Neurol       Date:  2010-11-17       Impact factor: 4.849

2.  A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.

Authors:  Matthew T Rondina; Nathan Wanner; Robert C Pendleton; Larry W Kraiss; Russell Vinik; Guy A Zimmerman; Marta Heilbrun; John M Hoffman; Kathryn A Morton
Journal:  Thromb Res       Date:  2011-07-29       Impact factor: 3.944

Review 3.  18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis.

Authors:  Ana María García Vicente; Roberto C Delgado-Bolton; Mariano Amo-Salas; Jesús López-Fidalgo; Ana Paula Caresia Aróztegui; José Ramón García Garzón; Javier Orcajo Rincón; María José García Velloso; María de Arcocha Torres; Soledad Alvárez Ruíz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-27       Impact factor: 9.236

4.  Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification.

Authors:  F J Pena Pardo; A M García Vicente; M Amo-Salas; J F López-Fidalgo; J A Garrido Robles; J Á de Ayala Fernández; P Del Saz Saucedo; M Muñoz Pasadas; A Soriano Castrejón
Journal:  Clin Transl Oncol       Date:  2016-05-02       Impact factor: 3.405

5.  The Utility of FDG-PET/CT in Clinically Suspected Paraneoplastic Neurological Syndrome: A Literature Review and Retrospective Case Series.

Authors:  Mark P Maskery; Jonathan Hill; John R Cain; Hedley C A Emsley
Journal:  Front Neurol       Date:  2017-06-01       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.